Immunological changes in the MPTP-induced Parkinson's disease mouse model
- 1 January 1993
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 42 (1), 33-37
- https://doi.org/10.1016/0165-5728(93)90209-h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Early effects of unilateral lesions of substantia nigra on immune reactivityNeuroscience Letters, 1992
- Hemispheric Asymmetry in the Effects of Substantia Nigra Lesioning on Lymphocyte Reactivity in MiceInternational Journal of Neuroscience, 1992
- Preproenkephalin mRNA and Methionine‐Enkephalin Increase in Mouse Striatum After 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine TreatmentJournal of Neurochemistry, 1991
- In Vivo Modulation of the Immune System by EnkephalinsInternational Journal of Neuroscience, 1990
- Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in miceLife Sciences, 1989
- Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigraBrain Research, 1987
- Modulation of T-Suppressor cell activity by central nervous system catecholamine depletionJournal of Neuroscience Research, 1987
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Enkephalins as immunomodulatorsInternational Journal of Immunopharmacology, 1983